[1]
Raza, H., Bhutta, M.E. and Siddique, M.H. 2024. Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus. Sultan Qaboos University Medical Journal. 24, 3 (Aug. 2024), 418–419. DOI:https://doi.org/10.18295/squmj.8.2024.050.